XERODERMA PIGMENTOSUM

Clinical trials for XERODERMA PIGMENTOSUM explained in plain language.

Never miss a new study

Get alerted when new XERODERMA PIGMENTOSUM trials appear

Sign up with your email to follow new studies for XERODERMA PIGMENTOSUM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1 Not yet finished but already full! 1 Completed 1

Early trial aims to train immune system to fight childhood cancers

Disease control Terminated

This early-phase study aimed to test the safety and find the right dose of a two-drug immunotherapy (nivolumab and ipilimumab) for children, teens, and young adults whose cancers had returned or stopped responding to standard treatments. The drugs work by helping the patient's ow…

Matched conditions: XERODERMA PIGMENTOSUM

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Apr 02, 2026 14:56 UTC

XERODERMA PIGMENTOSUM

Get alerted when new XERODERMA PIGMENTOSUM trials appear

Early trial aims to train immune system to fight childhood cancers